Stable-Tau Overexpression in Human Neuroblastoma Cells: An Open Door for Explaining Neuronal Death in Tauopathies

Annals of the New York Academy of Sciences

Volumn 1010, Issue , 2003, Pages 623-634

  Delobel, Patrice ^a   Mailliot, Christel ^a   Hamdane, Malika ^a   Sambo, Anne Véronique ^a   Bégard, Séverine ^a   Violleau, Anne ^a   Delacourte, André ^a   Buée, Luc ^a  

^a INSERM   (France)

Author keywords

Abnormal phosphorylation; Aggregation; Apoptosis; FTDP 17 (frontotemporal dementia with parkinsonism linked to chromosome 17); Hyperphosphorylation; Tau proteins

Indexed keywords

CASPASE; CELL PROTEIN; MICROTUBULE PROTEIN; TAU PROTEIN;

APOPTOSIS; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NERVE CELL DEGENERATION; NEUROBLASTOMA CELL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TAUOPATHY;

EID: 1342347848     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1299.115     Document Type: Conference Paper

References (29)

1. LEE, V.M., M. GOEDERT & J.Q. TROJANOWSKI. 2001. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 224: 1121-1159.
2. BUÉE, L., T. BUSSIÈRE, V. BUÉE-SCHERRER, et al. 2000. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33: 95-130.
3. GOEDERT, M. 2001. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases. Curr. Opin. Genet. Dev. 11: 343-351.
4. GOEDERT, M., M.G. SPILLANTINI, M.C. POTIER, et al. 1989. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8: 393-399.
5. GOEDERT, M., M.G. SPILLANTINI, R. JAKES, et al. 1989. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526.
6. LEE, G., R.L. NEVE & K.S. KOSIK. 1989. The microtubule binding domain of tau protein. Neuron 2: 1615-1624.
7. FORMAN, M.S., V.M. LEE & J.Q. TROJANOWSKI. 2000. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. J. Chem. Neuroanat. 20: 225-244.
8. GOEDERT, M. & M.G. SPILLANTINI. 2001. Tau gene mutations and neurodegeneration. Biochem. Soc. Symp. 67: 59-71.
9. DELOBEL, P., S. FLAMENT, M. HAMDANE, et al. 2002. Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. J. Biol. Chem. 277: 9199-9205.
10. SERGEANT, N., A. WATTEZ & A. DELACOURTE. 1999. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J. Neurochem. 72: 1243-1249.
11. DELACOURTE, A., Y. ROBITAILLE, N. SERGEANT, et al. 1996. J. Neuropathol. Exp. Neurol. 552: 159-168.
12. DELACOURTE, A. & L. BUÉE. 1997. Normal and pathological Tau proteins as factors for microtubule assembly. Int. Rev. Cytol. 171: 167-224.
13. SERGEANT, N., J.P. DAVID, D. LEFRANC, et al. 1997. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 412: 578-582.
14. CHAMBERS, C.B., J.M. LEE, J.C. TRONCOSO, et al. 1999. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann. Neurol. 46: 325-332.
15. PROBST, A., J. GOTZ, K.H. WIEDERHOLD, et al. 2000. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 99: 469-481.
16. BUÉE-SCHERRER, V., O. CONDAMINES, C. MOURTON-GILLES, et al. 1996. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res. Mol. Brain Res. 39: 79-88.
17. GOEDERT, M., R. JAKES, R.A. CROWTHER, et al. 1994. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 301: 871-877.
18. SERGEANT, N., B. SABLONNIERE, S. SCHRAEN-MASCHKE, et al. 2001. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10: 2143-2155.
19. MAILLIOT, C., N. SERGEANT, T. BUSSIERE, et al. 1998. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett. 433: 201-204.
20. CHAKRAVARTHY, B.R., T. WALKER, I. RASQUINHA, et al. 1999. Activation of DNA-dependent protein kinase may play a role in apoptosis of human neuroblastoma cells. J. Neurochem. 72: 933-942.
21. DUPONT-WALLOIS, L., P.E. SAUTIERE, C. COCQUERELLE, et al. 1995. Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. FEBS Lett. 357: 197-201.
22. LIPPKE, J.A., Y. GU, C. SARNECKI, et al. 1996. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271: 1825-1828.
23. GU, Y., C. SARNECKI, R.A. ALDAPE, et al. 1995. Cleavage of poly(ADP-ribose) polymerase by interleukin-1 beta converting enzyme and its homologs TX and Nedd-2. J. Biol. Chem. 270: 18715-18718.
24. CANU, N., L. DUS, C. BARBATO, et al. 1998. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18: 7061-7074.
25. FASULO, L., G. UGOLINI, M. VISINTIN, et al. 2000. The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75: 624-633.
26. DELOBEL, P., S. FLAMENT, M. HAMDANE, et al. 2002. Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. J. Neurochem. 83: 412-420.
27. PEREZ, M., F. HERNANDEZ, A. GOMEZ-RAMOS, et al. 2002. Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur. J. Biochem. 269: 1484-1489.
28. GOODE, B.L., M. CHAU, P.E. DENIS & S.C. FEINSTEIN. 2000. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease. J. Biol. Chem. 275: 38182-38189.
29. SERGEANT, N., J.P. DAVID, D. LEFRANC, et al. 1997. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 412: 578-582.